Global Finasteride Tablets Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Finasteride Tablets Market Research Report 2024
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
According to Mr Accuracy reports new survey, global Finasteride Tablets market is projected to reach US$ 155.9 million in 2029, increasing from US$ 118.4 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Finasteride Tablets market research.
Key manufacturers engaged in the Finasteride Tablets industry include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Finasteride Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Finasteride Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Finasteride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Segment by Type
1mg Tablet
5mg Tablet
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Finasteride Tablets report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Finasteride Tablets market is projected to reach US$ 155.9 million in 2029, increasing from US$ 118.4 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Finasteride Tablets market research.
Key manufacturers engaged in the Finasteride Tablets industry include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Finasteride Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Finasteride Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Finasteride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Segment by Type
1mg Tablet
5mg Tablet
Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Finasteride Tablets report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source